Fritextsökning
Innehållstyper
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Investerar 870 miljoner i Uppsala
GE Healthcare meddelade den 3 december att man beslutat investera 870 miljoner kronor i anläggningen i Uppsala de kommande tre åren.
-
Pfizer överväger nya bud
Obama-administrationens nya skatteregler hämmar inte bolagets köplust.
-
Anything is measurable
At the seminar "Du är vad jag mäter - hjärnans kemi i ett provrör", Jonas Bergquist, professor of analytical chemistry and neurochemistry, will dig deep into th...
-
New tools to fight bacteria
Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...
-
Varnar för Astra-preparat
FDA går ut med ännu en varning för läkemedelsklassen SGLT2-hämmare.
-
Vicore pharma besätter nyckelpositioner
Bolaget förstärker organisationen med tre nya nyckelpersoner.
-
How to get visitors to your booth
Food, ball throwing and laser engraved pens. There are many tricks to attract visitors to the stands at Scanlab.
-
75 million for research schools
Gothenburg University, Karolinska Institutet, Linköping University and Umeå University have received SEK 75 million from the Research Council. The money will be...
-
Diagnostics for personalized medicine
Per Matsson from Phadia anticipates changes in the standards for health care. Accordiing to him, expensive new drugs will create a market for more extensive diagnostics.
-
Early stage research and low turnaround dominates
Nordic science parks are full of advanced research performed by small companies but little research is done in later stages. Only a couple of the best performer...
-
Svensk hälsohub öppnar i Kina
H2 Health Hub påbörjar sin satsning på den kinesiska marknaden. Idag öppnar H2 tillsammans med en lokal partner en innovationshub i Hangzhou, Kina. Målet är att...
-
Per Norstedt, Regional Manager, AH Diagnostics
Why are you going to Scanlab+Biotech Forum?
-
USA-samarbete för Camanio
Camanio care inleder ett samarbete med den amerikanska rehabiliteringsorganisationen On with life.
-
Forskare undersöker samband mellan covid-19 och demens
"Hjärndimma" är ett av de symtom som beskrivits efter infektion med sars-cov-2. Forskare i Indien pekar på att demensrelaterade besvär kan tillta hos patienter ...
-
Lundbeck behind the first EU-approved intravenous migraine treatment
A preventive, intravenous treatment for migraines has been approved in the EU for the first time.
-
Mingling types - who to aim for and who to avoid:
Read about different mingling types - who are you?
-
Elypta awarded one million USD from the Star Trek creator’s foundation
Swedish company Elypta, which develops methods for early cancer detection, has been awarded one million USD from an unexpected source: a foundation set up in me...
-
Now it’s settled: The International Vaccine Institute will be located in Stockholm
The International Vaccine Institute, IVI, is establishing itself outside South Korea for the first time. Last week, the Swedish Parliament ratified the agreemen...
-
Lucka 14 - se vem som finns här
Det lackar mot jul och det vill vi uppmärksamma tillsammans med er. Varje dag fram till jul får vi här veta vad profiler i life science-världen har på sin önskelista.
-
Göteborgsforskare skapar banbrytande hudtest
Ny metod kan ge omfattande information om den mänskliga huden.
-
Fewer visitors but satisfied exhibitors
Biotech Forum Scanlab attracted fewer visitors than in 2008. Exhibition manager Bo Rasmussen is content, claiming that the exhibitors are very satisfied.
-
Collaboration for a simpler production of gene therapies launched
A collaboration between universities and companies aims at providing better production methods for the development of gene therapies. The initiative is led by J...
BREAKING